9500 Euclid Avenue
244 articles with Cleveland Clinic
First U.S. Patients Treated with Impella 5.5 with SmartAssist, a Minimally Invasive, Forward Flow Heart Pump
Three cardiac surgeons at Cleveland Clinic, Hackensack Meridian Health and Cedars-Sinai Medical Center are the first in the United States to implant Abiomed’s newest heart pump, the Impella 5.5 with SmartAssist. Ed Soltesz, MD, Mark Anderson, MD, and Danny Ramzy, MD, have each successfully implanted multiple pumps during cardiac procedures at their hospitals..
Enterprises will bring together technology and clinical excellence; Cleveland Clinic to act as League's Chief Medical Director
Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology
Anixa to Host a Conference Call Thursday, July 18, 2019, 4:30 p.m. ET to Discuss Agreement
In its 10th year, Cleveland Clinic’s annual Patient Experience: Empathy + Innovation Summit is partnering with global health information thought leader HIMSS.
Superstars Lionel Richie, Shania Twain, Snoop Dogg and More Appear at Keep Memory Alive's 23rd Annual Power of Love® Gala
Spectacular Night of Philanthropy Raised Funds for Cleveland Clinic Nevada
October 26 Research Roundup: New Cell Structures, Herpes and Alzheimer’s, Metformin Mechanism and...
10/26/2018There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Incidence of Alzheimer’s disease is projected to double in the next 40 years unless a cure or preventive measures are found. The U.S. Centers for Disease Control and Prevention published a new report in the journal Alzheimer’s & Dementia projecting the disease’s likely expansion, and for the firs...
Pliant Therapeutics Announces Research Collaboration with Cleveland Clinic to Develop New Disease Targets for Gastrointestinal Fibrosis
Pliant Therapeutics, Inc. today announced that they have entered into a multi-year joint research collaboration with Cleveland Clinic to accelerate the discovery of potential disease targets for gastrointestinal fibrosis.
9/5/2018On August 29, Chicago-based Tempus, which focuses on data analytics for molecular and clinical data, announced it had raised $110 million in Series E financing. This brought total money raised so far to $320 million. This also gave the company a valuation of $2 billion.
Citing safety concerns, a watchdog organization is calling on the National institutes of Health to halt enrollment in a clinical trial evaluating a treatment for sepsis that the organization said is risky and flawed.
Cleveland Clinic Florida has reclaimed the top spot, ranking No. 1 in the Miami-Fort Lauderdale market for 2018-2019, according to the newly released annual ranking of Best Hospitals by U.S. News & World Report.
Velano Vascular Adds Healthcare Veterans David R. Strand and Dr. Gary Kurtzman to Board of Directors
Vascular access technology innovator Velano Vascular today welcomed Safeguard Scientifics Healthcare Managing Director, Gary Kurtzman, MD and seasoned Chief Executive Officer and former hospital system Chief Operating Officer David R. Strand to its Board of Directors.
$53 million facility offers specialty care and outpatient surgery
Interim Results from Clinical Trial of Immunotherapy for Glioblastoma Show Significant Clinical Benefit
The research team behind an emerging immunotherapy for cancer will present interim findings from an ongoing clinical study in patients with brain cancer at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.
New facility increases Clinic's capacity to analyze patient samples, advance medical research and enhance clinical care
The ISCDD 2018 Award was presented to Dr. Cummings by Dr. Raymond Sanchez, the Chairman of the ISCDD Executive Committee, and Dr. Amir Kalali, Executive Secretary, ISCDD.